The immunometabolic checkpoint axis formed by the IDO1/AhR pathway and the HIF-1α pathway, which functionally antagonize each other via their competition for the shared transcriptional partner aryl hydrocarbon receptor nuclear translocator (ARNT), profoundly regulates the pathogenesis and progression of autoimmune diseases. The gene discussed is IDO1; the disease is autoimmune disease.